Overview
Borderline epithelial tumor of ovary, also known as borderline ovarian tumor (BOT) or ovarian tumor of low malignant potential, is a classification that has been marked as OBSOLETE in the Orphanet database (Orphanet code 206473). These tumors represent a distinct category of ovarian neoplasms that exhibit atypical epithelial proliferation greater than that seen in benign tumors but without the destructive stromal invasion characteristic of frank ovarian carcinoma. They primarily affect the female reproductive system, specifically the ovaries, and can be of serous, mucinous, endometrioid, clear cell, or transitional (Brenner) histological subtypes, with serous and mucinous being the most common. Borderline ovarian tumors typically present in women of reproductive age, often at an earlier stage than invasive ovarian cancers. Symptoms may include pelvic or abdominal pain, abdominal distension, bloating, and occasionally an incidentally discovered adnexal mass on imaging. Some patients may be asymptomatic. The prognosis is generally favorable compared to invasive ovarian carcinoma, with high survival rates, particularly when diagnosed at early stages. Treatment primarily involves surgical management, with the extent of surgery depending on the patient's age, desire for fertility preservation, and the stage of disease. Conservative fertility-sparing surgery (such as unilateral salpingo-oophorectomy or cystectomy) may be considered in younger patients, while complete surgical staging including bilateral salpingo-oophorectomy and hysterectomy may be recommended for patients who have completed childbearing. The role of adjuvant chemotherapy remains controversial and is generally not recommended for most borderline tumors. Long-term follow-up is important due to the possibility of late recurrence. The obsolete status of this Orphanet entry likely reflects reclassification or merging into a broader or updated disease category within the database.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Borderline epithelial tumor of ovary.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Borderline epithelial tumor of ovary at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Borderline epithelial tumor of ovary.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Borderline epithelial tumor of ovary.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Borderline epithelial tumor of ovary.
Start the conversation →Latest news about OBSOLETE: Borderline epithelial tumor of ovary
No recent news articles for OBSOLETE: Borderline epithelial tumor of ovary.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Borderline epithelial tumor of ovary
What is OBSOLETE: Borderline epithelial tumor of ovary?
Borderline epithelial tumor of ovary, also known as borderline ovarian tumor (BOT) or ovarian tumor of low malignant potential, is a classification that has been marked as OBSOLETE in the Orphanet database (Orphanet code 206473). These tumors represent a distinct category of ovarian neoplasms that exhibit atypical epithelial proliferation greater than that seen in benign tumors but without the destructive stromal invasion characteristic of frank ovarian carcinoma. They primarily affect the female reproductive system, specifically the ovaries, and can be of serous, mucinous, endometrioid, clear
How is OBSOLETE: Borderline epithelial tumor of ovary inherited?
OBSOLETE: Borderline epithelial tumor of ovary follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Borderline epithelial tumor of ovary typically begin?
Typical onset of OBSOLETE: Borderline epithelial tumor of ovary is adult. Age of onset can vary across affected individuals.